Top Markets
Coin of the day
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
Rangering i aksjer #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
Aksjekurs
$2.72
Sist synkronisert: 2023-10-19
Markedsverdi
$111.47M
Endring (1 dag)
-0.73%
Endring (1 år)
0.00%
Land
US
Handel Talaris Therapeutics, Inc. (TALS)

Kategori

Historikk for aksjesplitt for Talaris Therapeutics, Inc. (TALS)
Aksjen Talaris Therapeutics, Inc. (symbol: TALS) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 23, 2026.
Én TALS-aksje kjøpt før Aug 23, 2026 tilsvarer i dag 0 TALS-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH